{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:59Z","timestamp":1707524159168},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,28]]},"DOI":"10.7759\/cureus.11739","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T16:50:43Z","timestamp":1606582243000},"source":"Crossref","is-referenced-by-count":0,"title":["Physostigmine in Anticholinergic Poisoning: An Old Antidote With Resurgence"],"prefix":"10.7759","author":[{"given":"Nicholas  G","family":"Blackstone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bujji","family":"Ainapurapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12839","article-title":"Pharmacological management of anticholinergic delirium \u2010 theory, evidence and practice","volume":"81","author":"Dawson AH","year":"2016","unstructured":"Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium \u2010 theory, evidence and practice. Br J Clin Pharmacol. 2016, 81:516-524. 10.1111\/bcp.12839","journal-title":"Br J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0196-0644(80)80232-0","article-title":"Asystole complicating physostigmine treatment of tricyclic antidepressant overdose","volume":"11","author":"Pentel P","year":"1980","unstructured":"Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980, 11:588-590. 10.1016\/s0196-0644(80)80232-0","journal-title":"Ann Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(00)70057-6","article-title":"A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning","volume":"35","author":"Burns MJ","year":"2000","unstructured":"Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000, 35:374-381. 10.1016\/S0196-0644(00)70057-6","journal-title":"Ann Emerg Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2017.1342828","article-title":"Safety and effectiveness of physostigmine: a 10-year retrospective review","volume":"56","author":"Arens AM","year":"2017","unstructured":"Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review . Clin Toxicol . 2017, 56:101-107. 10.1080\/15563650.2017.1342828","journal-title":"Clin Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-019-00697-z","article-title":"Adverse effects of physostigmine","volume":"15","author":"Arens AM","year":"2019","unstructured":"Arens AM, Kearney T. Adverse effects of physostigmine. J Med Toxicol. 2019, 15:184-191. 10.1007\/s13181-019-00697-z","journal-title":"J Med Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-010-0077-7","article-title":"Timing and frequency of physostigmine redosing for antimuscarinic toxicity","volume":"6","author":"Rosenbaum C","year":"2010","unstructured":"Rosenbaum C, Bird SB. Timing and frequency of physostigmine redosing for antimuscarinic toxicity. J Med Toxicol. 2010, 6:386-392. 10.1007\/s13181-010-0077-7","journal-title":"J Med Toxicol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019846654","article-title":"A comparison of resource utilization in the management of anticholinergic delirium between physostigmine and nonantidote therapy","volume":"53","author":"Boley SP","year":"2019","unstructured":"Boley SP, Stellpflug SJ. A comparison of resource utilization in the management of anticholinergic delirium between physostigmine and nonantidote therapy. Ann Pharmacother. 2019, 53:1026-1032. 10.1177\/1060028019846654","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42815-physostigmine-in-anticholinergic-poisoning-an-old-antidote-with-resurgence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:02Z","timestamp":1707506462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42815-physostigmine-in-anticholinergic-poisoning-an-old-antidote-with-resurgence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.11739","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}